Cart
sales@molnova.com
N-Benzyloleamide
CAS No. 883715-21-7
N-Benzyloleamide( —— )
Catalog No. M31462 CAS No. 883715-21-7
N-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 297 | In Stock |
|
| 100MG | 445 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Benzyloleamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
-
DescriptionN-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number883715-21-7
-
Formula Weight371.6
-
Molecular FormulaC25H41NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (124.49 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Methyltetrazine-Amin...
Methyltetrazine-Amine is a methyl-substituted tetrazine amine used in the synthesis of PROTAC molecules.
-
Randaiol
Randaiol is a natural product from Magnolia hypoleuca.
-
Ebopiprant
Ebopiprant (OBE022) is an orally available, selective and potent prostaglandin F2α (PGF2α) receptor antagonist that interferes with the binding of PGF0126α to the FPR and can be used in the study of obesity.
